We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are three stocks with buy rank and strong value characteristics for investors to consider today, November 30th:
Werner Enterprises, Inc. (WERN - Free Report) : This transportation and logistics company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 3.6% over the last 60 days.
Ready CapitalCorp (RC - Free Report) : This publicly-traded mortgage REIT has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 2.8% over the last 60 days.
Ralph Lauren Corporation (RL - Free Report) : This apparel giant has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
Image: Bigstock
Top Ranked Value Stocks to Buy for November 30th
Here are three stocks with buy rank and strong value characteristics for investors to consider today, November 30th:
Werner Enterprises, Inc. (WERN - Free Report) : This transportation and logistics company has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings advancing 3.6% over the last 60 days.
Werner Enterprises, Inc. Price and Consensus
Werner Enterprises, Inc. price-consensus-chart | Werner Enterprises, Inc. Quote
Werner has a price-to-earnings ratio (P/E) of 14.40 compared with 15.30 for the industry. The company possesses a Value Score of A.
Werner Enterprises, Inc. PE Ratio (TTM)
Werner Enterprises, Inc. pe-ratio-ttm | Werner Enterprises, Inc. Quote
Ready CapitalCorp (RC - Free Report) : This publicly-traded mortgage REIT has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings rising 2.8% over the last 60 days.
Ready Capital Corp Price and Consensus
Ready Capital Corp price-consensus-chart | Ready Capital Corp Quote
Ready Capital has a price-to-earnings ratio (P/E) of 8.23, compared with 11.90 for the industry. The company possesses a Value Score of A.
Ready Capital Corp PE Ratio (TTM)
Ready Capital Corp pe-ratio-ttm | Ready Capital Corp Quote
Ralph Lauren Corporation (RL - Free Report) : This apparel giant has a Zacks Rank #2 (Buy), and seen the Zacks Consensus Estimate for its current year earnings increasing 2.3% over the last 60 days.
Ralph Lauren Corporation Price and Consensus
Ralph Lauren Corporation price-consensus-chart | Ralph Lauren Corporation Quote
Ralph Lauren has a price-to-earnings ratio (P/E) of 16.40, compared with 23.90 for the industry. The company possesses a Value Score of A.
Ralph Lauren Corporation PE Ratio (TTM)
Ralph Lauren Corporation pe-ratio-ttm | Ralph Lauren Corporation Quote
See the full list of top ranked stocks here
Learn more about the Value score and how it is calculated here.
3 Medical Stocks to Buy Now
The greatest discovery in this century of biology is now at the flashpoint between theory and realization. Billions of dollars in research have poured into it. Companies are already generating revenue, and cures for a variety of deadly diseases are in the pipeline.
So are big potential profits for early investors. Zacks has released an updated Special Report that explains this breakthrough and names the best 3 stocks to ride it.
See them today for free >>